Skip to main content

Vira Shield 6

This page contains information on Vira Shield 6 for veterinary use.
The information provided typically includes the following:
  • Vira Shield 6 Indications
  • Warnings and cautions for Vira Shield 6
  • Direction and dosage information for Vira Shield 6

Vira Shield 6

This treatment applies to the following species:
Company: Elanco US (Farm Animal)

Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine

Killed Virus

For Use In Animals Only

Vira Shield 6 Indications

This product has been shown to be effective for the vaccination of healthy cattle against disease caused by infectious bovine rhinotracheitis (IBR), bovine virus diarrhea (BVD Type 1 and BVD Type 2), parainfluenza Type 3 (PI3), and bovine respiratory syncytial (BRSV) viruses. The duration of immunity for BVD Type 2 is at least 11 months. The duration of immunity for the remaining antigens in this product has not been established. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

Produced from non-cytopathic (BVD Type 1 and BVD Type 2) and cytopathic (BVD Type 1) isolates. This product is safe for use in pregnant cows and heifers.

ADJUVANT: Xtend™ SP.

Directions For Use

Shake well before using. Administer 5 mL subcutaneously. In accordance with Beef Quality Assurance guidelines, this product should be administered subcutaneously (under the skin) in the neck. Revaccinate in 4 to 5 weeks. Vaccinate dairy cows at dry-off. Historically, annual revaccination with a single dose has been recommended for this product.The need for this booster has not been established. For advice on revaccination frequency, consultation with a veterinarian is recommended.

Precautions

Store out of direct sunlight at 2° to 8°C (35° to 46°F). DO NOT FREEZE. Use entire contents when first opened. Do not mix with other products, except as specified on the label. In case of human exposure, contact a physician. Do not vaccinate within 60 days prior to slaughter. Transient swelling may occur at the site of injection. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine.

Contains amphotericin B, gentamicin, and thimerosal as preservatives.

VLN/PCN 196/1185.20

Elanco US, Inc., Fort Dodge, IA 50501 USA, Phone 800-428-4441

Vira Shield, Xtend, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

10 Doses

50 mL

YL102399A

50 Doses

250 mL

YL102399B

CPN: 1114088.5

ELANCO US, INC.
Distributed by ELANCO US, INC.
2500 INNOVATION WAY, GREENFIELD, IN, 46140
Customer Service:   317-276-1262
Technical Service:   800-428-4441
Website:   www.elanco.us
Email:   elanco@elanco.com
Every effort has been made to ensure the accuracy of the Vira Shield 6 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2022 Animalytix LLC. Updated: 2021-11-29